PMID: 9650689Jul 3, 1998Paper

Successful treatment of progressive myoclonus epilepsy with TRH

Pediatric Neurology
C TanakaK Takeshita

Abstract

Thyrotropin-releasing hormone (TRH) is sometimes used for the treatment of neurologic disorders such as intractable epilepsy and spinocerebellar degeneration. A 14-year-old girl with progressive myoclonus epilepsy was treated with intravenous TRH for 12 months. Clinical symptoms, such as cortical myoclonus and cerebellar signs, were improved, and P25-N33 amplitudes of somatosensory-evoked potentials decreased after TRH therapy. P100 amplitudes on flash visual-evoked potentials and photosensitivity on electroencephalograms also decreased but only temporarily. Changes in neurophysiologic findings after TRH therapy indicate that TRH inhibits hyperexcitability in the sensorimotor cortex and the visual cortex. Therefore, intravenous TRH therapy is recommended as an alternative therapy in the treatment of progressive myoclonus epilepsy.

Citations

Dec 6, 2001·Current Treatment Options in Neurology·Basim M. Uthman, Andreas Reichl
Apr 12, 2003·Brain & Development·Katsuhiko OguroHiroatsu Hojo
Jan 30, 2002·Pediatric Neurology·Michael J Kubek, Bhuwan P Garg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Barrel cortex

Here is the latest research on barrel cortex, a region of somatosensory and motor corticies in the brain, which are used by animals that rely on whiskers for world exploration.